These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Long term chrysotherapy: incidence of toxicity and efficacy during sequential time periods. Kean WF; Anastassiades TP Arthritis Rheum; 1979 May; 22(5):495-501. PubMed ID: 156026 [TBL] [Abstract][Full Text] [Related]
26. Treatment complications of rheumatoid arthritis with gold, hydroxychloroquine, D-penicillamine, and levamisole. Husain Z; Runge LA J Rheumatol; 1980; 7(6):825-30. PubMed ID: 6451692 [TBL] [Abstract][Full Text] [Related]
27. Comparison of penicillamine and gold treatment in early rheumatoid arthritis. Mäkisara P; Nissilä M; Kajander A; Martio J; von Essen R; Anttila P; Mäkisara GL Scand J Rheumatol; 1978; 7(3):166-70. PubMed ID: 103190 [TBL] [Abstract][Full Text] [Related]
28. A method of comparing the toxicities of disease suppressive agents: possible application to a comparison between D-penicillamine and chloroquine. Redda A; Anastassiades T Clin Invest Med; 1984; 7(1):65-71. PubMed ID: 6426836 [TBL] [Abstract][Full Text] [Related]
29. Should one use second-line agents such as gold and D-penicillamine in a patient with active rheumatoid arthritis and asymptomatic microscopic haematuria for which no cause can be determined? Bird HA Br J Rheumatol; 1989 Feb; 28(1):39. PubMed ID: 2492869 [No Abstract] [Full Text] [Related]
30. Effects of long-term aurothiomalate and D-penicillamine treatments on renal function and urinary excretion of prostanoids in patients with rheumatoid arthritis. Seppälä E; Lehtinen K; Isomäki H; Nissilä M; Harmoinen A; Mörsky P; Koivula T; Vapaatalo H Int J Clin Pharmacol Res; 1988; 8(3):149-56. PubMed ID: 3136089 [TBL] [Abstract][Full Text] [Related]
31. Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group. J Rheumatol; 1987 Feb; 14(1):67-73. PubMed ID: 2952797 [TBL] [Abstract][Full Text] [Related]
32. Is the mechanism of action during treatment of rheumatoid arthritis with penicillamine and gold thiomalate the same? Jellum E; Aaseth J; Munthe E Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):136-9. PubMed ID: 122761 [No Abstract] [Full Text] [Related]
33. A long-term five-year randomized controlled trial of hydroxychloroquine, sodium aurothiomalate, auranofin and penicillamine in the treatment of patients with rheumatoid arthritis. Jessop JD; O'Sullivan MM; Lewis PA; Williams LA; Camilleri JP; Plant MJ; Coles EC Br J Rheumatol; 1998 Sep; 37(9):992-1002. PubMed ID: 9783766 [TBL] [Abstract][Full Text] [Related]
35. Does the order of second-line treatment in rheumatoid arthritis matter? Steven MM; Hunter JA; Murdoch RM; Capell HA Br Med J (Clin Res Ed); 1982 Jan; 284(6309):79-81. PubMed ID: 6797663 [TBL] [Abstract][Full Text] [Related]
37. An assessment of penicillamine therapy in rheumatoid arthritis and the influence of previous gold therapy. Webley M; Coomes EN J Rheumatol; 1979; 6(1):20-4. PubMed ID: 439106 [TBL] [Abstract][Full Text] [Related]
38. The relationship between D-penicillamine--induced proteinuria and prior gold nephropathy. Billingsley LM; Stevens MB Johns Hopkins Med J; 1981 Feb; 148(2):64-7. PubMed ID: 7206401 [TBL] [Abstract][Full Text] [Related]
39. Serum sulfhydryl levels in rheumatoid patients treated with gold thiomalate and penicillamine. Haataja M; Nissilä M; Ruutsalo HM Scand J Rheumatol; 1978; 7(4):212-4. PubMed ID: 104378 [TBL] [Abstract][Full Text] [Related]
40. HLA antigens and toxic reactions to sodium aurothiomalate in patients with rheumatoid arthritis. Bensen WG; Moore N; Tugwell P; D'Souza M; Singal DP J Rheumatol; 1984 Jun; 11(3):358-61. PubMed ID: 6234391 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]